Cargando…

Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues

BACKGROUND: Proliferation and tumor differentiation captured by the genomic grade index (GGI) are important prognostic indicators in breast cancer (BC) especially for the estrogen receptor positive (ER+) disease. The aims of this study were to convert this microarray index to a qRT-PCR assay (PCR-GG...

Descripción completa

Detalles Bibliográficos
Autores principales: Toussaint, Jérôme, Sieuwerts, Anieta M, Haibe-Kains, Benjamin, Desmedt, Christine, Rouas, Ghizlane, Harris, Adrian L, Larsimont, Denis, Piccart, Martine, Foekens, John A, Durbecq, Virginie, Sotiriou, Christos
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2756282/
https://www.ncbi.nlm.nih.gov/pubmed/19744330
http://dx.doi.org/10.1186/1471-2164-10-424
_version_ 1782172488831074304
author Toussaint, Jérôme
Sieuwerts, Anieta M
Haibe-Kains, Benjamin
Desmedt, Christine
Rouas, Ghizlane
Harris, Adrian L
Larsimont, Denis
Piccart, Martine
Foekens, John A
Durbecq, Virginie
Sotiriou, Christos
author_facet Toussaint, Jérôme
Sieuwerts, Anieta M
Haibe-Kains, Benjamin
Desmedt, Christine
Rouas, Ghizlane
Harris, Adrian L
Larsimont, Denis
Piccart, Martine
Foekens, John A
Durbecq, Virginie
Sotiriou, Christos
author_sort Toussaint, Jérôme
collection PubMed
description BACKGROUND: Proliferation and tumor differentiation captured by the genomic grade index (GGI) are important prognostic indicators in breast cancer (BC) especially for the estrogen receptor positive (ER+) disease. The aims of this study were to convert this microarray index to a qRT-PCR assay (PCR-GGI), which could be realized on formalin fixed paraffin embedded samples (FFPE), and to assess its prognostic performance and predictive value of clinical benefit in early and advanced ER+ BC patients treated with tamoxifen. METHODS: The accuracy and concordance of the PCR-GGI with the GGI was assessed using BC patients for which frozen and FFPE tissues as well as microarray data were available (n = 19). The evaluation of the prognostic value of the PCR-GGI was assessed on FFPE material using a consecutive series of 212 systemically treated early BC patients. The predictive performance for tamoxifen benefit was assessed using two ER+ BC populations treated either with adjuvant tamoxifen only (n = 77+139) or first-line tamoxifen for advanced disease (n = 270). RESULTS: The PCR-GGI is based on the expression of 8 genes (4 representative of the GGI and 4 reference genes). A significant correlation was observed between the microarray-derived GGI and the qRT-PCR assay using frozen (ρ = 0.95, p < 10E-06) and FFPE material (ρ = 0.89, p < 10E-06). The prognostic performance of the PCR-GGI was confirmed on FFPE samples (HR(univar. )= 1.89; [95CI:1.01-3.54], p = 0.05). The PCR-GGI further identified two subgroups of patients with statistically different time to distant metastasis free survival (DMFS) across the two cohorts of ER+ BC patients treated with adjuvant tamoxifen. Additionally, the PCR-GGI was associated with response to tamoxifen in the advanced setting (HR(univar. )= 1.98; [95CI:1.51-2.59], p = 6.9E-07). CONCLUSION: PCR-GGI recapitulates in an accurate and reproducible manner the performances of the GGI using frozen and FFPE samples.
format Text
id pubmed-2756282
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27562822009-10-03 Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues Toussaint, Jérôme Sieuwerts, Anieta M Haibe-Kains, Benjamin Desmedt, Christine Rouas, Ghizlane Harris, Adrian L Larsimont, Denis Piccart, Martine Foekens, John A Durbecq, Virginie Sotiriou, Christos BMC Genomics Methodology Article BACKGROUND: Proliferation and tumor differentiation captured by the genomic grade index (GGI) are important prognostic indicators in breast cancer (BC) especially for the estrogen receptor positive (ER+) disease. The aims of this study were to convert this microarray index to a qRT-PCR assay (PCR-GGI), which could be realized on formalin fixed paraffin embedded samples (FFPE), and to assess its prognostic performance and predictive value of clinical benefit in early and advanced ER+ BC patients treated with tamoxifen. METHODS: The accuracy and concordance of the PCR-GGI with the GGI was assessed using BC patients for which frozen and FFPE tissues as well as microarray data were available (n = 19). The evaluation of the prognostic value of the PCR-GGI was assessed on FFPE material using a consecutive series of 212 systemically treated early BC patients. The predictive performance for tamoxifen benefit was assessed using two ER+ BC populations treated either with adjuvant tamoxifen only (n = 77+139) or first-line tamoxifen for advanced disease (n = 270). RESULTS: The PCR-GGI is based on the expression of 8 genes (4 representative of the GGI and 4 reference genes). A significant correlation was observed between the microarray-derived GGI and the qRT-PCR assay using frozen (ρ = 0.95, p < 10E-06) and FFPE material (ρ = 0.89, p < 10E-06). The prognostic performance of the PCR-GGI was confirmed on FFPE samples (HR(univar. )= 1.89; [95CI:1.01-3.54], p = 0.05). The PCR-GGI further identified two subgroups of patients with statistically different time to distant metastasis free survival (DMFS) across the two cohorts of ER+ BC patients treated with adjuvant tamoxifen. Additionally, the PCR-GGI was associated with response to tamoxifen in the advanced setting (HR(univar. )= 1.98; [95CI:1.51-2.59], p = 6.9E-07). CONCLUSION: PCR-GGI recapitulates in an accurate and reproducible manner the performances of the GGI using frozen and FFPE samples. BioMed Central 2009-09-10 /pmc/articles/PMC2756282/ /pubmed/19744330 http://dx.doi.org/10.1186/1471-2164-10-424 Text en Copyright © 2009 Toussaint et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology Article
Toussaint, Jérôme
Sieuwerts, Anieta M
Haibe-Kains, Benjamin
Desmedt, Christine
Rouas, Ghizlane
Harris, Adrian L
Larsimont, Denis
Piccart, Martine
Foekens, John A
Durbecq, Virginie
Sotiriou, Christos
Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues
title Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues
title_full Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues
title_fullStr Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues
title_full_unstemmed Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues
title_short Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues
title_sort improvement of the clinical applicability of the genomic grade index through a qrt-pcr test performed on frozen and formalin-fixed paraffin-embedded tissues
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2756282/
https://www.ncbi.nlm.nih.gov/pubmed/19744330
http://dx.doi.org/10.1186/1471-2164-10-424
work_keys_str_mv AT toussaintjerome improvementoftheclinicalapplicabilityofthegenomicgradeindexthroughaqrtpcrtestperformedonfrozenandformalinfixedparaffinembeddedtissues
AT sieuwertsanietam improvementoftheclinicalapplicabilityofthegenomicgradeindexthroughaqrtpcrtestperformedonfrozenandformalinfixedparaffinembeddedtissues
AT haibekainsbenjamin improvementoftheclinicalapplicabilityofthegenomicgradeindexthroughaqrtpcrtestperformedonfrozenandformalinfixedparaffinembeddedtissues
AT desmedtchristine improvementoftheclinicalapplicabilityofthegenomicgradeindexthroughaqrtpcrtestperformedonfrozenandformalinfixedparaffinembeddedtissues
AT rouasghizlane improvementoftheclinicalapplicabilityofthegenomicgradeindexthroughaqrtpcrtestperformedonfrozenandformalinfixedparaffinembeddedtissues
AT harrisadrianl improvementoftheclinicalapplicabilityofthegenomicgradeindexthroughaqrtpcrtestperformedonfrozenandformalinfixedparaffinembeddedtissues
AT larsimontdenis improvementoftheclinicalapplicabilityofthegenomicgradeindexthroughaqrtpcrtestperformedonfrozenandformalinfixedparaffinembeddedtissues
AT piccartmartine improvementoftheclinicalapplicabilityofthegenomicgradeindexthroughaqrtpcrtestperformedonfrozenandformalinfixedparaffinembeddedtissues
AT foekensjohna improvementoftheclinicalapplicabilityofthegenomicgradeindexthroughaqrtpcrtestperformedonfrozenandformalinfixedparaffinembeddedtissues
AT durbecqvirginie improvementoftheclinicalapplicabilityofthegenomicgradeindexthroughaqrtpcrtestperformedonfrozenandformalinfixedparaffinembeddedtissues
AT sotiriouchristos improvementoftheclinicalapplicabilityofthegenomicgradeindexthroughaqrtpcrtestperformedonfrozenandformalinfixedparaffinembeddedtissues